Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response

突变型EZH2通过重编程免疫反应诱导淋巴瘤癌前微环境

阅读:2
作者:Wendy Béguelin ,Matt Teater ,Cem Meydan ,Kenneth B Hoehn ,Jude M Phillip ,Alexey A Soshnev ,Leandro Venturutti ,Martín A Rivas ,María T Calvo-Fernández ,Johana Gutierrez ,Jeannie M Camarillo ,Katsuyoshi Takata ,Karin Tarte ,Neil L Kelleher ,Christian Steidl ,Christopher E Mason ,Olivier Elemento ,C David Allis ,Steven H Kleinstein ,Ari M Melnick

Abstract

Follicular lymphomas (FLs) are slow-growing, indolent tumors containing extensive follicular dendritic cell (FDC) networks and recurrent EZH2 gain-of-function mutations. Paradoxically, FLs originate from highly proliferative germinal center (GC) B cells with proliferation strictly dependent on interactions with T follicular helper cells. Herein, we show that EZH2 mutations initiate FL by attenuating GC B cell requirement for T cell help and driving slow expansion of GC centrocytes that become enmeshed with and dependent on FDCs. By impairing T cell help, mutant EZH2 prevents induction of proliferative MYC programs. Thus, EZH2 mutation fosters malignant transformation by epigenetically reprograming B cells to form an aberrant immunological niche that reflects characteristic features of human FLs, explaining how indolent tumors arise from GC B cells.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。